闭环控制系统治疗儿童1型糖尿病的随机试验
这项16周、多中心、随机、开放标签、平行组试验将101名6至13岁1型糖尿病患儿按3:1比例分配至闭环胰岛素输注系统组(78例)或传感器增强胰岛素泵组(23例)。主要终点为连续血糖监测所测血糖在70至180 mg/dL目标范围内的时间百分比。闭环组从基线53±17%升至67±10%(16周治疗均值),对照组从51±16%升至55±13%,平均校正差异11个百分点(相当于每天2.6小时),95%CI 7至14,P<0.001。两组血糖低于70 mg/dL的中位时间百分比均较低(闭环组1.6%,对照组1.8%),两组均未发生糖尿病酮症酸中毒或严重低血糖。
要点
- 在6至13岁1型糖尿病患儿中,闭环系统组血糖在70至180 mg/dL目标范围内的时间百分比为67±10%,对照组为55±13%,平均校正差异11个百分点(95%CI 7至14,P<0.001)。
- 闭环组血糖在目标范围内时间从基线53±17%升至67±10%,对照组从51±16%升至55±13%,校正差异相当于每天2.6小时。
- 两组血糖低于70 mg/dL的中位时间百分比均低:闭环组1.6%,对照组1.8%。
- 两组均未发生糖尿病酮症酸中毒或严重低血糖。
- 闭环组系统处于闭环模式的中位时间百分比为93%(四分位距91至95)。
适用人群与场景
- 6至13岁1型糖尿病患儿,基线糖化血红蛋白水平范围为5.7%至10.1%。
诊断标准与关键阈值
- 主要终点为连续血糖监测所测血糖在70至180 mg/dL目标范围内的时间百分比。
研究设计与关键结果
- 16周、多中心、随机、开放标签、平行组试验,101名6至13岁1型糖尿病患儿按3:1随机分配至闭环胰岛素输注系统组(78例)或传感器增强胰岛素泵组(23例)。
- 闭环组血糖在70至180 mg/dL目标范围内的时间百分比从基线53±17%升至67±10%(16周治疗均值),对照组从51±16%升至55±13%,平均校正差异11个百分点(相当于每天2.6小时),95%CI 7至14,P<0.001。
- 两组血糖低于70 mg/dL的中位时间百分比均低:闭环组1.6%,对照组1.8%。
- 闭环组系统处于闭环模式的中位时间百分比为93%(四分位距91至95)。
- 两组均未发生糖尿病酮症酸中毒或严重低血糖。
证据类型、等级与局限
- 证据类型:多中心随机开放标签平行组试验。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A closed-loop system of insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes.
METHODS: In a 16-week, multicenter, randomized, open-label, parallel-group trial, we assigned, in a 3:1 ratio, children 6 to 13 years of age who had type 1 diabetes to receive treatment with the use of either a closed-loop system of insulin delivery (closed-loop group) or a sensor-augmented insulin pump (control group). The primary outcome was the percentage of time that the glucose level was in the target range of 70 to 180 mg per deciliter, as measured by continuous glucose monitoring.
RESULTS: A total of 101 children underwent randomization (78 to the closed-loop group and 23 to the control group); the glycated hemoglobin levels at baseline ranged from 5.7 to 10.1%. The mean (±SD) percentage of time that the glucose level was in the target range of 70 to 180 mg per deciliter increased from 53±17% at baseline to 67±10% (the mean over 16 weeks of treatment) in the closed-loop group and from 51±16% to 55±13% in the control group (mean adjusted difference, 11 percentage points [equivalent to 2.6 hours per day]; 95% confidence interval, 7 to 14; P<0.001). In both groups, the median percentage of time that the glucose level was below 70 mg per deciliter was low (1.6% in the closed-loop group and 1.8% in the control group). In the closed-loop group, the median percentage of time that the system was in the closed-loop mode was 93% (interquartile range, 91 to 95). No episodes of diabetic ketoacidosis or severe hypoglycemia occurred in either group.
CONCLUSIONS: In this 16-week trial involving children with type 1 diabetes, the glucose level was in the target range for a greater percentage of time with the use of a closed-loop system than with the use of a sensor-augmented insulin pump. (Funded by Tandem Diabetes Care and the National Institute of Diabetes and Digestive and Kidney Diseases; ClinicalTrials.gov number, NCT03844789.).
参考来源
- Breton MD, Kanapka LG, Beck RW, et al. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020. PMID: 32846062. doi:10.1056/NEJMoa2004736
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。